What factors affect the prognosis for prostate cancer?

Several factors affect the prognosis of prostate cancer, including the stage of cancer, how abnormal or aggressive is cancer and general health of the affected person. Through treatment, some men are recovering from prostate cancer, while others don't. However, recovery does not ensure that the disease does not appear. In addition, those who cannot be cured of prostate cancer can undergo hormonal therapy to extend their lives. If cancer spreads behind the prostate, it may be more difficult to treat. There are four phases of prostate cancer, each with certain properties. In general, even when cancer is placed only in the prostate, phase II is when the cancer has progressed, but is still only in the prostate and phase III is when the cancer has spread to the prostate, perhaps even key vesicles. Stage IV is when Rakovinase has spread to other areas of the body.

Gleason's score or measure of how abnCancer is or aggressive, is another factor that affects prognosis for prostate cancer. In fact, Gleason's score is one of the elements that the doctor takes into account in the presentation of the disease. Gleason's score is the sum of two Gleason degrees, degrees on a scale of 1 to 5, which are assigned to cells depending on how abnormal appear. Gleason 5 level indicates a higher risk of repetition.

There may be many cells with different Gleason marks, so the two signs used to calculate Gleason score are the two most common degrees between the cells. Since Gleason's degree is on a scale of 1 to 5, the Gleason score is on a scale of 2 to 10. Gleason score between 2 and 4 represents a low quality, less aggressive cancer; The score between 5 and 7 represents middle -class cancer; and the score between 8 and 10 represents high quality and aggressive cancer. High Gleason score suggests a higher probability that cancer has spread beyond the prostate.

overall health canE also affect the prognosis of prostate cancer. This is because health conditions can reduce the type of treatment that the affected person can monitor. Although some men will not need prostate cancer treatment, to have a limited range of treatment options may be unfavorable to others.